During the past decade, The George Institute for Global Health conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The George Institute for Global Health" #1 collaborator was "First Affiliated Hospital of Chengdu Medical College, China" with 1 trials as a collaborator, "Huashan Hospital" with 1 trials as a collaborator, "Shanghai East Hospital, China" with 1 trials as a collaborator, "Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, China" with 1 trials as a collaborator and "The University of Western Australia" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "The George Institute for Global Health" are "Cerebrovascular Disorders" (1 trials), "Intracerebral Hemorrhage" (1 trials) and "Stroke, Acute" (1 trials). Many other conditions were trialed in "The George Institute for Global Health" in a lesser frequency.

Most popular intervention types in "The George Institute for Global Health" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Start antiplatelet monotherapy" (1 trials) and "urapidil" (1 trials). Other intervention names were less common.

The vast majority of trials in "The George Institute for Global Health" are 2 trials for "All" genders.

Currently, there are NaN active trials in "The George Institute for Global Health". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in The George Institute for Global Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The George Institute for Global Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".